In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes

Cancer Chemotherapy and Pharmacology

Volumn 21, Issue 2, 1988, Pages 150-155

  Schrøder, Henrik ^a   Fogh, Karsten ^a   Herlin, Troels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; METHOTREXATE; METHOTREXATE POLYGLUTAMATE;

AGE; DRUG TISSUE LEVEL; ERYTHROCYTE; HUMAN; HUMAN CELL; METABOLISM;

6-MERCAPTOPURINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; ERYTHROCYTE AGING; ERYTHROCYTE COUNT; ERYTHROCYTES; HUMAN; LEUKEMIA, LYMPHOCYTIC; MATHEMATICS; METHOTREXATE; PEPTIDES; POLYGLUTAMIC ACID; REGRESSION ANALYSIS; RETICULOCYTES; SUPPORT, NON-U.S. GOV'T;

EID: 0023875413     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00257363     Document Type: Article

References (31)

1. Efflux of methotrexate and its polyglutamate derivatives from hepatic cells in vitro
2. Polygammaglutamyl derivatives of methotrexate
3. The binding of folyl and antifolyl polyglutamates to hemoglobin
4. The transport and accumulation of methotrexate in human erythrocytes
5. Intracellular metabolites of methotrexate
6. Pharmacokinetcs of methotrexate in erythrocytes in psoriasis
7. Synthesis, retention and biological activity of methotrexate polyglutamates in cultured human breast cancer cells
8. Analysis of methotrexate polyglutamate derivatives in vivo
9. A rapid radiochemical ligand binding assay for methotrexate
10. Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug
11. Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with methotrexate
12. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow
13. In situ methotrexate polyglutamate formation in rat issues
14. The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ
15. Separation and identification of subpicomole amounts of methotrexate polyglutamates in animal and human biopsy material
16. The decline of catalytic enzyme activty concentration of the in vivo ageing erythrocytes in the man, the dog and the rat
17. In vivo lability of glucose-6-phosphate dehydrogenase in Gde- and GdMediterranean deficiency
18. Human erythrocyte separation according to age on a discontinuous Percoll density gradient
19. Pharmacokinetics of erythrocyte methotrexate after highdose methotrexate
20. Methotrexate polyglutamates in human sarcoma tissues and erythrocytes: significance for efficacy of high-dose MTX therapy
21. Pharmacokinetics and organ distribution of methotrexate in the rat
22. Methotrexate pharmacolinetics in agefractionated erythrocytes
23. Methotrexate in neutrophils of children with acute lymphoblastic leukemia
24. Methotrexate in erythrocytes of patients with psoriasis
25. Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment
26. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly lowdose oral methotrexate therapy of children with acute lymphoblastic leukemia
27. The decline in energetic metabolism with ageing of the erythrocyte and its relationship to cell death
28. The in vivo distribution of methotrexate between plasma and erythrocytes
29. Metabolism of MTX to polyglutamyl derivatives and the relationship to folate pools in vivo